.FDA rejects psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Accept MDMA Treatment, Looking For Even More Study The Nyc TimesFDA Declines Ecstasy-Based Medicine The Wall Street JournalFDA rejects to accept unique MDMA treatment to treat post-traumatic stress disorder, with ask for more hearing data CNNFDA turns down to begin with psychedelic to manage PTSD, asking for even more research The Washington Post.